Changes to the Code
H.R. 4752 · Reducing Hereditary Cancer Act · Introduced The text as a member of Congress first filed it. Most bills never get further than this.
In committee · step 2 of 5
42 U.S.C. § 1395m Special payment rules for particular items and services
1 change the bill asks for here, 1 carried out
- Carried out:
Section 1834(c)(2)(A) of the Social Security Act (42 U.S.C. 1395m(c)(2)(A)) is amended, in the matter preceding clause (i), by striking
subparagraph (B)
and insertingsubparagraph (B) and section 1862(q)
.
§ 1395m(c)Payment and standards for screening mammography(1)–(2)
Start of § 1395m to (c)(1)(A) unchanged ·
(B) if the screening mammography is conducted by a facility that has a certificate (or provisional certificate) issued under section 263b of this title.
(2) Frequency covered
(A) In general Subject to revision by the Secretary under subparagraph (B)[inserted: and section 1862(q)]—
(i) no payment may be made under this part for screening mammography performed on a woman under 35 years of age;
(ii) payment may be made under this part for only one screening mammography performed on a woman over 34 years of age, but under 40 years of age; and
Rest of § 1395m unchanged ·
42 U.S.C. § 1395x Definitions
4 changes the bill asks for here, 2 carried out
- Not carried out:
by striking
and
at the end of subparagraph (II);The bill strikes “and” at the end of § 1395x(s)(2)(II), but the text there doesn't end with it. The law may have changed since the bill was drafted.
Technical detail
“and” is not at the end of /us/usc/t42/s1395x/s/2/II - Not carried out:
by striking the period and inserting
; and
at the end of subparagraph (JJ); andWe can't read how this instruction is worded yet, so it isn't shown in the text.
Technical detail
no-pattern: striking the period and inserting QTEXT at the end of subparagraph (X); and - Carried out:
by inserting after subparagraph (JJ) the following new subparagraph:
(KK) in the case of an individual with a personal or family history of a hereditary cancer gene mutation or a personal or family history suspicious for hereditary cancer, germline mutation testing.; and
The section already has a provision under this letter or number, so it would have two.
- Carried out:
by adding at the end the following new subsection:
(nnn) Germline mutation testing.— The term “germline mutation testing” means genetic testing for germline mutations that is in accordance with evidence-based, clinical practice guidelines specifically addressing genetic testing, screening, and management of individuals with …
The section already has a provision under this letter or number, so it would have two.
This bill puts a provision under a letter or number this section already uses, so the section would have two. The law has probably changed since the bill was written.
§ 1395x(s)Medical and other health services(2)–(3)
Start of § 1395x to (s)(2)(HH) unchanged ·
(II) marriage and family therapist services (as defined in subsection (lll)(1)) and mental health counselor services (as defined in subsection (lll)(3)); and 3
(JJ) lymphedema compression treatment items (as defined in subsection (mmm)); and
(KK) [inserted: in the case of an individual with a personal or family history of a hereditary cancer gene mutation or a personal or family history suspicious for hereditary cancer, germline mutation testing.]
(KK) multi-cancer early detection screening tests (as defined in subsection (nnn));
(3) diagnostic X-ray tests (including tests under the supervision of a physician, furnished in a place of residence used as the patient’s home, if the performance of such tests meets such conditions relating to health and safety as the Secretary may find necessary and including diagnostic mammography if conducted by a facility that has a certificate (or provisional certificate) issued under section 354 of the Public Health Service Act [42 U.S.C. 263b]), diagnostic laboratory tests, and other diagnostic tests;
§ 1395x(nnn)–(nnn)
(s)(4)–(nnn)(1) unchanged ·
(ii) appropriate for individuals entitled to benefits under part A or enrolled under part B.
(2) NCD process In making determinations under paragraph (1)(C) regarding the coverage of a new test, the Secretary shall use the process for making national coverage determinations (as defined in section 1395ff(f)(1)(B) of this title) under this subchapter.
(nnn) [inserted: Germline mutation testing.—] [inserted: The term “germline mutation testing” means genetic testing for germline mutations that is in accordance with evidence-based, clinical practice guidelines specifically addressing genetic testing, screening, and management of individuals with inherited mutations associated with increased cancer risk that—]
(1) [inserted: have been developed by a nationally recognized oncology professional organization, including the National Comprehensive Cancer Network, the American Society of Clinical Oncology, the Society of Gynecologic Oncology, or any other oncology professional organization specified by a medicare administrative contractor with a contract under section 1874A; and]
(2) [inserted: in the case of conflicting guidelines developed by more than one nationally recognized oncology professional organization, the least restrictive of such guidelines, as determined by such a medicare administrative contractor.]
42 U.S.C. § 1395y Exclusions from coverage and medicare as secondary payer
5 changes the bill asks for here, 5 carried out
- Carried out:
by striking
and
at the end of subparagraph (O); - Carried out:
by adding
and
at the end of subparagraph (P); and - Carried out:
by adding at the end the following new subparagraph:
(Q) in the case of germline mutation testing as defined in section 1861(lll), which is performed more than once with respect to an individual described in such section;.
- Carried out:
Section 1862 of the Social Security Act (42 U.S.C. 1395y) is amended by adding at the end the following new subsection:
(p) Coverage of certain risk-Reducing surgeries.— In the case of an individual described in section 1861(s)(2)(II) for whom, based on evidence-based, clinical practice guidelines described in section 1861(lll), surgery would reduce the risk of developing cancer, such …
- Carried out:
Section 1862 of the Social Security Act (42 U.S.C. 1395y), as amended by section 3, is amended by adding at the end the following new subsection:
(q) Coverage of evidence-Based screenings for individuals with a hereditary cancer gene mutation.— In the case of an individual who is determined pursuant to genetic testing to have a hereditary cancer (germline) gene mutation, the Secretary shall increase any frequency …
§ 1395y(a)Items or services specifically excluded(1)–(3)
Start of § 1395y to (a)(1)(M) unchanged ·
(N) in the case of ultrasound screening for abdominal aortic aneurysm which is performed more frequently than is provided for under section 1395x(s)(2)(AA) of this title,
(O) in the case of kidney disease education services (as defined in paragraph (1) of section 1395x(ggg) of this title), which are furnished in excess of the number of sessions covered under paragraph (4) of such section,[struck: and]
(P) in the case of personalized prevention plan services (as defined in section 1395x(hhh)(1) of this title), which are performed more frequently than is covered under such section;[inserted: and]
(Q) [inserted: in the case of germline mutation testing as defined in section 1861(lll), which is performed more than once with respect to an individual described in such section;]
(2) for which the individual furnished such items or services has no legal obligation to pay, and which no other person (by reason of such individual’s membership in a prepayment plan or otherwise) has a legal obligation to provide or pay for, except in the case of Federally qualified health center services;
(3) which are paid for directly or indirectly by a governmental entity (other than under this chapter and other than under a health benefits or insurance plan established for employees of such an entity), except in the case of rural health clinic services, as defined in section 1395x(aa)(1) of this title, in the case of Federally qualified health center services, as defined in section 1395x(aa)(3) of this title, in the case of services for which payment may be made under section 1395qq(e) of this title, and in such other cases as the Secretary may specify;
§ 1395y(o)–(q)
(a)(4)–(o)(2) unchanged ·
(3) Promulgation of regulations The Secretary shall promulgate regulations to carry out this subsection, section 1395w–112(b)(7) of this section (including as applied pursuant to section 1395w–27(f)(3)(D) of this title), and section 1396b(i)(2)(C) of this title.
(4) Credible allegation of fraud In carrying out this subsection, section 1395w–112(b)(7) of this title (including as applied pursuant to section 1395w–27(f)(3)(D) of this title), and section 1396b(i)(2)(C) of this title, a fraud hotline tip (as defined by the Secretary) without further evidence shall not be treated as sufficient evidence for a credible allegation of fraud.
(p) [inserted: Coverage of certain risk-Reducing surgeries.—] [inserted: In the case of an individual described in section 1861(s)(2)(II) for whom, based on evidence-based, clinical practice guidelines described in section 1861(lll), surgery would reduce the risk of developing cancer, such risk-reducing surgery shall be considered reasonable and necessary for treatment of illness under subsection (a)(1)(A).]
(q) [inserted: Coverage of evidence-Based screenings for individuals with a hereditary cancer gene mutation.—] [inserted: In the case of an individual who is determined pursuant to genetic testing to have a hereditary cancer (germline) gene mutation, the Secretary shall increase any frequency limitations (or other limitations on coverage otherwise applicable under this title) for any evidence-based screenings furnished to such individual, to be in compliance with evidence-based, clinical practice guidelines described in section 1861(lll), or as determined appropriate by the Secretary, but not less frequently than on an annual basis. For the purposes of this subsection, evidence-based screenings shall include screening mammography, breast screening MRI, colonoscopy, PSA testing, and any additional evidence-based screening modalities appropriate for high-risk individuals as recommended by such guidelines.]